Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA
27/06/2022 13:16
June 27 (Reuters) - AcuCort AB ACUC.TE :
* ACUCORT IS GRANTED SME STATUS BY THE EUROPEAN MEDICINES
AGENCY,
EMA
* ACUCORT AB - ACHIEVED SME STATUS IS VALID UNTIL DECEMBER
31,
2023
Source text for Eikon: ID:nPreKcFpga
Further company coverage: ACUC.TE
Recent news on AcuCort AB
See all newsBrief: Acucort Plans To Apply For U.S. Market Approval For Zeqmelit In 2026
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA